R. Patel

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

Gerard G. Hanna, Louise Murray, R. Patel et al. · Clinical Oncology · 2017 · 274 citations · Full text

Medicine, Oncology, Radiation Oncology +16

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Patricia Díez, Gerard G. Hanna, K. Aitken et al. · Clinical Oncology · 2022 · 129 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer

John Conibear, Brendan J. Chia, Yenting Ngai et al. · BMJ Open · 2018 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Inter-Observer Variability in Target Volume Delineations of Benign and Metastatic Brain Tumours for Stereotactic Radiosurgery: Results of a National Quality Assurance Programme

S. Growcott, Todd Dembrey, R. Patel et al. · Clinical Oncology · 2019 · 42 citations

Medicine, Neurosurgery, Oncology +16

Stereotactic radiosurgery for benign brain tumors: Results of multicenter benchmark planning studies

David Eaton, Jonathan R. I. Lee, R. Patel et al. · Practical Radiation Oncology · 2018 · 31 citations

Medicine, Neurosurgery, Surgery +14